Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL32P8, or ribosomal protein L32 pseudogene 8, is a non-coding genomic sequence derived from the functional ribosomal protein L32 gene (RPL32), which normally encodes one of the structural proteins of the 60S ribosomal subunit[1][3][5][6]. As a processed pseudogene, RPL32P8 does not produce a functional protein and has no established biological role or disease association. The parent gene RPL32 is essential for ribosome function and protein synthesis, but RPL32P8 itself is considered a genomic relic without clinical utility. Its aliases include RPL32_2_419[1]. There is no evidence that RPL32P8 is used as a biomarker or therapeutic target, and no drugs or safety concerns are documented for this pseudogene. If you are seeking information about the functional ribosomal protein L32 (RPL32) or its mitochondrial paralog, refer to entries for "Ribosomal protein L32" (RPL32) or "Mitochondrial ribosomal protein L32" (MRPL32)[3][4][5]. These proteins have defined cellular roles and disease relevance, but RPL32P8 itself does not.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L32 pseudogene 8 (RPL32P8).